
Generate Biomedicines offers Generate Platform
Generate Platform is a generative biology platform that designs novel protein therapeutics.
- Currently Offered

Generate Platform is a generative biology platform that designs novel protein therapeutics.
Generate Platform from Generate:Biomedicines applies machine learning to design protein sequences for therapeutic use, including antibodies and other engineered proteins. Its generate-build-measure-learn loop pairs computational design with laboratory synthesis and testing.
Biopharmaceutical research teams use the platform for protein drug programs, and the company advances its own pipeline of generated candidates alongside partner collaborations.


Biology-First AI platform predicts disease-matched compounds using multi-omics human data and functional validation.



Cyrus Platform is Cyrus Biotechnology's computational protein design offering combining AI and Rosetta-based design with laboratory mutagenesis screening.


AI-enabled natural-product drug discovery platform organizing plant chemistry into a searchable library with machine-learning translation and automated screening.


EVA combines machine learning and automated laboratory testing to optimize therapeutic antibodies.


mBER is Manifold Bio's open-source AI framework for designing antibody binders for in vivo drug discovery.
Biology-First AI platform predicts disease-matched compounds using multi-omics human data and functional validation.

Cradle Platform is an AI system that engineers proteins from laboratory data.

Cyrus Platform is Cyrus Biotechnology's computational protein design offering combining AI and Rosetta-based design with laboratory mutagenesis screening.

AI-enabled natural-product drug discovery platform organizing plant chemistry into a searchable library with machine-learning translation and automated screening.

EVA combines machine learning and automated laboratory testing to optimize therapeutic antibodies.

mBER is Manifold Bio's open-source AI framework for designing antibody binders for in vivo drug discovery.





Pharma.ai is Insilico Medicine's generative AI platform for drug discovery, target identification, and molecule design.


AI platform for de novo antibody and protein design against challenging drug targets.


ProGen is Salesforce's open BSD-3 protein language-modeling suite for protein engineering and design.



Biomedical AI platform that grounds biopharma R&D decisions in validated biology.



Absci's Integrated Drug Creation platform pairs generative-AI antibody design with its SoluPro microbial cell-line protein production system.


GEMS (Genesis Exploration of Molecular Space) is a generative AI platform for small-molecule drug discovery.


AI-driven platform that designs, builds, tests and learns from lipid nanoparticle formulations for targeted nucleic acid delivery.


Isomorphic Labs' Drug Design Engine builds on AlphaFold to predict biomolecular structures for drug discovery.


Nucleic acid design platform from Atombio for generating, evaluating, validating, and visualizing mRNA and aptamer designs.


Foundation-model platform for designing sequence-based medicines including siRNA, ASO, mRNA, and peptides.


AI-guided cyclic-oligonucleotide platform for designing ASO, siRNA, and sgRNA drug candidates.
EvoGen is a generative AI platform that designs novel therapeutic proteins.

Machine learning platform for drug discovery and development.

Pharma.ai is Insilico Medicine's generative AI platform for drug discovery, target identification, and molecule design.

AI platform for de novo antibody and protein design against challenging drug targets.

ProGen is Salesforce's open BSD-3 protein language-modeling suite for protein engineering and design.

Makya is a generative AI platform that designs novel drug-like molecules for medicinal chemistry teams.

Biomedical AI platform that grounds biopharma R&D decisions in validated biology.

HyperBind is an AI antibody design platform that learns from experimental feedback.

Absci's Integrated Drug Creation platform pairs generative-AI antibody design with its SoluPro microbial cell-line protein production system.

GEMS (Genesis Exploration of Molecular Space) is a generative AI platform for small-molecule drug discovery.

AI-driven platform that designs, builds, tests and learns from lipid nanoparticle formulations for targeted nucleic acid delivery.

Isomorphic Labs' Drug Design Engine builds on AlphaFold to predict biomolecular structures for drug discovery.

Nucleic acid design platform from Atombio for generating, evaluating, validating, and visualizing mRNA and aptamer designs.

Foundation-model platform for designing sequence-based medicines including siRNA, ASO, mRNA, and peptides.

AI-guided cyclic-oligonucleotide platform for designing ASO, siRNA, and sgRNA drug candidates.
